Patents by Inventor Chongbo HU

Chongbo HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20240116975
    Abstract: The present application relates to novel compounds that have modulating or activating effect on the activity of adenosine A3 receptor, preparation methods for the series of compounds, pharmaceutical compositions of the series of compounds, and pharmaceutical uses of the series of compounds.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 11, 2024
    Inventors: Chongbo HU, Jinqi YE, Shuhua PAN, Ning Hu, Tingting PAN, Long ZHAO, Zhengshu CHEN, Sanxing SUN
  • Triazolotriazine derivatives as A2A receptor antagonists
    Patent number: 11858942
    Abstract: The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: January 2, 2024
    Assignee: ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD.
    Inventors: Sanxing Sun, Jinqi Ye, Long Zhao, Chongbo Hu, Zhengshu Chen
  • Triazolotriazine derivatives as A2A receptor antagonists
    Patent number: 11845751
    Abstract: The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: December 19, 2023
    Assignee: ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD.
    Inventors: Sanxing Sun, Long Zhao, Chongbo Hu, Zhengshu Chen, Jinqi Ye
  • USE OF TRIAZOLOTRIAZINE DERIVATIVE IN TREATMENT OF DISEASES
    Publication number: 20230048888
    Abstract: The present application relates to use of a triazolotriazine derivative or a pharmaceutically acceptable solvate or salt thereof in the preparation of a drug for treating diseases, and a method for treating diseases.
    Type: Application
    Filed: December 25, 2020
    Publication date: February 16, 2023
    Applicant: ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD.
    Inventors: Sanxing SUN, Zhengshu CHEN, Jinqi YE, Long ZHAO, Chongbo HU, Yong YANG, Feng GUAN, Shuhua PAN, Ning HU, Tingting PAN, Guowei SONG, Fangjie HOU
  • TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
    Publication number: 20210332055
    Abstract: The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
    Type: Application
    Filed: June 26, 2018
    Publication date: October 28, 2021
    Inventors: Sanxing SUN, Long ZHAO, Chongbo HU, Zhengshu CHEN, Jinqi YE
  • TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
    Publication number: 20210292334
    Abstract: The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
    Type: Application
    Filed: June 26, 2018
    Publication date: September 23, 2021
    Inventors: Sanxing SUN, Jinqi YE, Long ZHAO, Chongbo HU, Zhengshu CHEN